ReichelH.Medical management of renal hyperpara thyroidism. Pulse treatment with vitamin D metabolites or not?Nephrol Dial Transplant1994; 9: 1368–70.
3.
SlatopolskyE., DelmezJ.A.Pathogenesis of secondary hyperparathyroidism.Am J Kidney Dis1994; 23: 229–36.
4.
CoburnJ.W.Mineral metabolism and renal bone dis ease: effects of CAPD versus hemodialysis.Kidney Int1993; 43(Suppl 40): S92–S100.
5.
SlatopolskyE., WeertsC., ThielanJ., HorstR., HarterH., MartinK.J.Marked suppression of secondary hyperparathyroidism by intravenous administration of 1, 25 dihydroxyvitamin D3 in uremic patients.J Clin Invest1984; 74: 2136–43.
6.
RitzE.Vitamin D metabolism in renal disease.J R Soc Med1992; 26: 394–9.
7.
KwanJ.T.C., AlmondM.K., BeerJ.C., NoonanK., EvansS.J.W., CunninghamJ.Pulse oral calcitriol in uraemic patients: rapid modification of parathyroid response to calcium.Nephrol Dial Transplant1992; 7: 829–34.
8.
ShigematsuT., KawaguchiY., UnemuraS.Suppression of secondary hyperparathyroidism in chronic dialysis patients by single oral weekly dose of 1, 25-di-hydroxycholecalciferol.Internal Med1993; 32: 695–701.
9.
MartinK.J., BallaI.S., DomotoD.T., BlalockS., WeindelMPulse oral calcitriol for the treatment of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis: preliminary observations.Am J Kidney Dis1992; 19: 540–5.